1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
Turnaround Potential
139.60 0.66 (0.48%)
65.74% Gain from 52W Low
503.7K
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 10 Sep 2025 for the purpose of Baird 2025 Global Healthcare Conference See details

Detailed Stock Analysis for Neurocrine Biosciences, Inc. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in